ImmunityBio (IBRX) : 9-year performance

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 673
• Founded by Patrick Soon-Shiong in 2014 
• Headquartered in San Diego, California
• https://immunitybio.com

Ticker: IBRX 

• 2 months later (10 Dec 24)